Human Enhancement Drugs is an impressively thorough and much needed contribution. To my knowledge, this is the most wide-ranging exploration of human enhancing drugs. Filled with new ideas and exceptional scholars, this is a must-have for anyone wishing to understand the wide world of pharmaceutical enhancement in contemporary culture.
John Gleaves, Professor of Kinesiology, California State University, Fullerton, USA
This important new book provides a fascinating guide to research on human enhancement drugs. As these substances increasingly challenge the boundaries between real and fake, legal and illegal, pleasure and harm, it is absolutely appropriate that the book includes a wide range of critical perspectives. It brings together many of the leading researchers on this topic from criminology, sport and exercise science, public health and other fields. It uses new data from around the world to provide multi-disciplinary insights which push forward our knowledge of what it means to be human in the 21st century.
Alex Stevens, Professor in Criminal Justice, School of Social Policy, Sociology and
Social Research, University of Kent, UK
Its become a clich that the use of drugs seems to be part of the human condition whether used to cure disease or to ameliorate suffering, or used for pleasure, socializing, and religion. The opium that relieved pain could also be used for relaxation and pleasure. Less well noticed, and less the subject of academic reflection, is the use of drugs for human enhancement. This is not only the preserve of elite athletes and doping scandals, or rich people with access to private medical clinics: being fitter and stronger, looking better, feeling better, thinking better, having better sex are part of a seemingly unending quest to go beyond normal, to exceed the initial limits of our bodies and minds. This excellent edited collection brings together some of the best thinkers in this field. It opens up a wide range of issues concerning who is using human enhancement drugs, why they are using them, and where they get them. It prompts key issues about whether and how we respond to the desire for human enhancement, and the challenges and complexities of regulating the drugs that many people seek.
Gerry Stimson, Emeritus Professor, Imperial College London, UK
Human Enhancement Drugs
Despite increasing interest in the use of human enhancement drugs (HEDs), our understanding of this phenomenon and the regulatory framework used to address it has lagged behind. Encompassing public health, epidemiology, neuroethics, sport science, criminology, and sociology, this book brings together a broad spectrum of scholarly insights and research expertise from leading authorities to examine key international issues in the field of HEDs. As traditional and other new drug markets have occupied much of the academic attention, there has been a lack of scholarly focus on human enhancement drugs. This book provides readers with a much-needed understanding of the illicit drug market of HEDs. The authors, from a variety of cultural contexts, disciplines and perspectives, include both academics and practitioners. Topics explored in this collection amongst others include:
The anti-doping industry and performance and image enhancing drugs
Steroids and gender
The use of cognitive enhancing drugs in academia
The use of sunless synthetic tanning products
The (online) trade of HEDs
Regulations of the enhancement drugs market
This collection will serve as a reference for students, academics, practitioners, law enforcement and others working in this area to reflect on the current state of research and consider future priorities. This detailed exploration will provide a valuable knowledge base for those interested in human enhancement drugs, while also promoting critical discussion.
Katinka van de Ven is a Research Fellow as part of the Drug Policy Modelling Program (DPMP) at the Social Policy Research Centre (SPRC), University of New South Wales. Katinkas research focuses on the use and supply of performance and image enhancing drugs (PIEDs), which includes projects surrounding the prevention of PIED use, harm reduction policies and improving healthcare services for users. She is Honorary Research Fellow at the Public Health Institute, Liverpool John Moores University. Katinka is Editor-in-Chief of Performance Enhancement & Health and the Director of the Human Enhancement Drug Network (HEDN) (www.humanenhancementdrugs.com).
Kyle J. D. Mulrooney is a lecturer in Criminology at the University of New England and the co-director of the Centre for Rural Criminology (UNE). His primary field of research is the Sociology of punishment in which he has examined issues ranging from the nexus between penal populism and political culture to the areas of drug policy and rural crime. He is also particularly interested in the use, supply, and regulation of enhancement drugs. Kyle holds a PhD in Cultural and Global Criminology from the University of Kent and Universitt Hamburg, an MA in the Sociology of Law from the International Institute for the Sociology of Law and a BA (Honours) in Criminology and Justice from the University of Ontario Institute of Technology.
Jim McVeigh is the Director of the Public Health Institute at Liverpool John Moores University. He has worked within health/public health for over 30 years and has built an international reputation within the field of human enhancement drug use, in particular, the use of anabolic steroids and associated drugs within the general population.
Routledge Studies in Crime and Society
Mothering and Desistance in Re-Entry
Venezia Michalsen
Cyber-risk and Youth
Digital Citizenship, Privacy and Surveillance
Michael Adorjan and Rosemary Ricciardelli
Gun Studies
Interdisciplinary Approaches to Politics, Policy, and Practice
Edited by Jennifer Carlson, Harel Shapira and Kristin A. Goss
The Myth of the Crime Decline
Exploring Change and Continuity in Crime and Harm
Justin Kotz
Execution by Family
A Theory of Honor Violence
Mark Cooney
Changing Narratives of Youth Crime
From Social Causes to Threats to the Social
Bernd Dollinger
Human Enhancement Drugs
Edited by Katinka van de Ven, Kyle J.D. Mulrooney and Jim McVeigh
Organized Crime and Terrorist Networks
Edited by Vincenzo Ruggiero
Private Security and Domestic Violence
The Risks and Benefits of Private Security Companies Working With Victims of Domestic Violence
Diarmaid Harkin
For more information about this series, please visit: https://www.routledge.com/Routledge-Studies-in-Crime-and-Society/book-series/RSCS
Human Enhancement Drugs
Edited by Katinka van de Ven,
Kyle J. D. Mulrooney and
Jim McVeigh
First published 2020
by Routledge
2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN
and by Routledge
52 Vanderbilt Avenue, New York, NY 10017
Routledge is an imprint of the Taylor & Francis Group, an informa business
2020 selection and editorial matter, Katinka van de Ven, Kyle J. D. Mulrooney and Jim McVeigh; individual chapters, the contributors.
The right of Katinka van de Ven, Kyle J. D. Mulrooney and Jim McVeigh to be identified as the authors of the editorial matter, and of the authors for their individual chapters, has been asserted in accordance with sections 77 and 78 of the Copyright, Designs and Patents Act 1988.
